Suppr超能文献

配制基础:实施美国药典第797章无菌药物制剂配制的注意事项,第6部分:2008年对第797章的修订

Basics of compounding: considerations for implementing United States pharmacopeia chapter 797 pharmaceutical compounding sterile preparations, part 6: 2008 revisions to chapter 797.

作者信息

Allen Loyd V, Okeke Claudia C

机构信息

International Journal of Pharmaceutical Compounding, Edmond, Oklahoma.

出版信息

Int J Pharm Compd. 2008 Mar-Apr;12(2):136-44.

Abstract

United States Pharmacopeia Chapter 797 Pharmaceutical Compounding-Sterile Preparations pertains to all preadministration manipulations and procedures involved in the preparation of sterile compounds for application, implantation, infusion, inhalation, injection, insertion, instillation, or irrigation, including preparation, storage and transportation. The chapter does not pertain to actual clinical administration of compounded sterile preparations to patients. The intent of Chapter 797 is simply to prevent patient harm and fatalities that may result from nonsterility , excessive endotoxin load, large content errors in strength of correct ingredients, or the presence of incorrect ingredients. Because the achievement of sterility requires that facilities meet minimum cleanliness standards, that personnel be trained adequately and undergo periodic testing and training in sterilization techniques, and that appropriate principles and practices be appied to sustain solution stability, compliance with Chapter 797, and those that have already met the new standards seem to support them strongly. A number of significant changes have been made to Chapter 797, and this article discusses these changes.

摘要

《美国药典》第797章“药物配制 - 无菌制剂”适用于为应用、植入、输注、吸入、注射、插入、滴注或冲洗而制备无菌化合物所涉及的所有给药前操作和程序,包括制备、储存和运输。本章不适用于将配制好的无菌制剂实际临床给药给患者的过程。第797章的目的仅仅是防止因不无菌、内毒素负荷过高、正确成分强度的大量含量误差或存在错误成分而可能导致的患者伤害和死亡。由于实现无菌要求设施符合最低清洁标准,人员得到充分培训并接受灭菌技术的定期测试和培训,以及应用适当的原则和做法来维持溶液稳定性,遵守第797章以及那些已经符合新标准的人似乎强烈支持这些标准。第797章已做出了一些重大更改,本文将讨论这些更改。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验